Navigation Links
Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases
Date:4/29/2008

NESS ZIONA, Israel and SOPHIA-ANTIPOLIS, France, April 29 /PRNewswire/ -- Foamix Ltd, a global leader in the development of dermatological foam medications and Galderma, a worldwide specialty pharmaceutical company focused on dermatology, today announced that they have signed an agreement to develop an innovative medicated foam jointly. This new treatment contains a novel drug for the therapy of certain skin diseases.

Under this agreement, Foamix will develop the foam formulation of the product and Galderma will subsequently conduct all other activities (clinical, non-clinical, etc). Foamix will receive staged payments on successful completion of the technical milestones of the project.

About Foamix:

Headquartered in Ness Ziona, Israel, Foamix Ltd. is a leading developer of topical foams for dermatology and gynecology. Foamix's state-of-the-art foams provide controlled delivery of a variety of active ingredients. Foamix is a privately held company, whose business model is based on partnering with leading pharma companies to develop products utilizing its proprietary foam technologies. Foamix is currently collaborating with 10 pharmaceutical companies on 11 projects in the development of proprietary dermatological and gynecologic foam drugs, and has its own in-house pipeline of dermatological and gynecological drugs in foam presentation. Foamix holds 4 US patents and has 62 US patents pending, with further filings worldwide.

For additional information, please visit http://www.foamix.co.il.

About Galderma:

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully integrated specialty pharmaceutical company dedicated exclusively to the field of dermatology. The Company is present in 65 countries, with over 1,000 sales representatives and is committed to improving the health of skin with an extensive line of products to treat a range of dermatol
'/>"/>

SOURCE Foamix Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
2. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
3. Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
4. Report on 750 New Medicines in Development for Cancer Released in Baton Rouge
5. Pregnant Women Need Omega-3 to Boost Infant Development
6. Aida Announces New Anti-Cancer Drug Under Development
7. ViroPharma Announces Discontinuation of HCV-796 Development
8. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
9. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... RIVIERA BEACH, Fla., Dec. 14 Perry ... 40 years, announces the launch of the Sigma ... advanced technology of the Sigma Elite is available ... www.perrybaromedical.com ) and has a Patent Pending. ,, ... ,, Data Capture Via Computerized System for ...
(Date:12/14/2009)... Conn., Dec. 14 Zargis Medical Corp., ... SPDE ) and a spin-off from Siemens Corporate ... that it has begun selling its award-winning Zargis ... ,, Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope ... "2009 Innovation of the Year." ...
(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that ... to announce that its affiliated fund has closed a ... in equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: ... the growth of Imaging Diagnostic Systems, Southridge has paved ... in the field of early breast cancer detection," said ...
Breaking Medicine Technology:Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2The right messenger for a healthy immune response 9284 1The right messenger for a healthy immune response 9284 2Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 1US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 2US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 3US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 52116 4
(Date:12/14/2009)... Physician Staff , ... La Jolla, Calif. (Vocus) -- ... Sedwitz, MD, as the new chief of staff of the 372-bed ... physician team on Jan. 1, 2010. , , , , ,During ... to Scripps La Jolla’s administrative staff and its board of directors. ...
(Date:12/14/2009)... of Steve Pasierb, President ,, NEW YORK, ... Michigan,s Monitoring the Future study (MTF) -- the largest ... 10th and 12th graders -- underscores that teens, intentional ... to be a cause for concern, with an alarming ... friends and relatives. ,, Teen Abuse ...
(Date:12/14/2009)... -- The Hemophilia Federation of America (HFA) expresses ... the Teamsters Local 929 and the American Red ... system depends on skilled workers to provide clean, ... into products such as clotting factor for use ... ,, The Division of Blood Services at the ...
(Date:12/14/2009)... had been treated, hadn,t spread, study finds , , MONDAY, ... the risk of death in male colon cancer survivors, ... 1986, included 668 men who,d been treated for stage ... had not spread (nonmetastatic cancer). Every two years, the ... new cancer and disease diagnoses, as well as their ...
(Date:12/14/2009)... protection, study finds, , , MONDAY, Dec. 14 (HealthDay News) ... their morning without a cup or two of java: ... developing type 2 diabetes. , That,s the conclusion ... coffee you drink, the lower your risk of diabetes. ... percent reduction in the risk of diabetes, the researchers ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... : , , , ... to interact with care providers online are leading causes of patient dissatisfaction ... approach in choosing providers that can make their visits as efficient as possible ... $31 billion of direct adoption incentives are available through American Recovery ...
... Travelers are warned of side effect that could hamper ... The widely used cancer drug capecitabine can cause people ... when they,re trying to enter the United States, an ... in medical oncology at the National Cancer Centre in ...
... in Kandahar, Afghanistan could help surgeons prepare for civilian ... served two tours at the hospital. Dr. Vivian ... at the Schulich School of Medicine & Dentistry at ... at the London Health Sciences Centre. He spent two ...
... Technology, a leading provider of revenue cycle solutions ... announced the firm,s selection as one of the ... one of the top 100 companies playing a ... http://www.newscom.com/cgi-bin/prnh/20090527/LA23009LOGO ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA89162LOGO )"Red ...
... Johnson recognized by business leaders for vision, determination and ... Search America , a part of ... health care, today announced that its president, Daniel Johnson, ... & Young Entrepreneur of the Year(R) Award in Minnesota ...
... to develop new and more effective therapies to fight ... Team" of scientists and clinicians that is co-led by ... Department of Energy,s Lawrence Berkeley National Laboratory. , The ... Entertainment Industry Foundation charitable organization aimed at moving cancer ...
Other Medicine News:Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 2Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 3Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 4Health News:Fingerprints May Vanish With Cancer Drug 2Health News:Sharing surgical lessons from the Canadian field hospital in Afghanistan 2Health News:Recondo Technology Wins Red Herring 100 North America Award 2Health News:SearchAmerica(R) President Named as a Finalist for the Ernst & Young Entrepreneur of the Year(R) Award 2Health News:SearchAmerica(R) President Named as a Finalist for the Ernst & Young Entrepreneur of the Year(R) Award 3Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 2Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 3
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
CEMEX Fast Set is a solution for multiple indications and preferences. It is a self-contained delivery system in a convenient 70gm size....
... Techno-Aide provides the highest level ... highest quality lead protective eyewear. ... + tolerance allowed. Mfg supervised by ... All lens meet or exceed standards ...
This flexiable metal clip-on easily attaches to most frames and allows for excellent radiation protection. Not available with side shields or in prescription....
Medicine Products: